Company intelligence
ReadOn Therapeutics gGmbh
A not-for-profit drug-development company, developing readthrough compounds for EB
About ReadOn Therapeutics gGmbh
ReadOn Therapeutics is a non-profit biotechnology organisation focused on developing readthrough therapeutics for Epidermolysis Bullosa (EB), with an initial focus on dystrophic EB caused by nonsense mutations. Our vision is to make nonsense read-through a validated, scaleable therapeutic category, developing functional cure for EB patients and hundreds of rare diseases. We operate at the intersection of translational science, rare disease research, and patient-centred drug development, working collaboratively with researchers, clinicians, biotech partners, and the EB community to accelerate progress toward meaningful treatments. ReadOn Therapeutics is based in Munich, Germany.
Verified activity
Signals from ReadOn Therapeutics gGmbh
1 published signal